Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 422

Similar articles for PubMed (Select 18331272)

1.

FK506 and erectile function preservation in the cavernous nerve injury model: optimal dosing and timing.

Mulhall JP, Müller A, Donohue JF, Golijanin D, Tal R, Akin-Olugbade Y, Kobylarz K, Cohen-Gould L, Bennett NE, Scardino P.

J Sex Med. 2008 Jun;5(6):1334-44. doi: 10.1111/j.1743-6109.2008.00776.x. Epub 2008 Mar 5.

PMID:
18331272
2.

The functional and structural consequences of cavernous nerve injury are ameliorated by sildenafil citrate.

Mulhall JP, Müller A, Donohue JF, Mullerad M, Kobylarz K, Paduch DA, Tal R, Li PS, Cohen-Gould L, Scardino PT.

J Sex Med. 2008 May;5(5):1126-36. doi: 10.1111/j.1743-6109.2008.00794.x. Epub 2008 Mar 4.

PMID:
18331274
3.

The effect of hyperbaric oxygen therapy on erectile function recovery in a rat cavernous nerve injury model.

Müller A, Tal R, Donohue JF, Akin-Olugbade Y, Kobylarz K, Paduch D, Cutter SC, Mehrara BJ, Scardino PT, Mulhall JP.

J Sex Med. 2008 Mar;5(3):562-70. doi: 10.1111/j.1743-6109.2007.00727.x. Epub 2008 Jan 11.

PMID:
18194179
4.

FK506 and sildenafil promote erectile function recovery after cavernous nerve injury through antioxidative mechanisms.

Lagoda G, Jin L, Lehrfeld TJ, Liu T, Burnett AL.

J Sex Med. 2007 Jul;4(4 Pt 1):908-16.

PMID:
17627738
5.

Intracavernous growth differentiation factor-5 therapy enhances the recovery of erectile function in a rat model of cavernous nerve injury.

Fandel TM, Bella AJ, Lin G, Tantiwongse K, Lin CS, Pohl J, Lue TF.

J Sex Med. 2008 Aug;5(8):1866-75. doi: 10.1111/j.1743-6109.2008.00881.x. Epub 2008 Jun 28.

PMID:
18564148
6.
7.

FK1706 enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat.

Bella AJ, Hayashi N, Carrion RE, Price R, Lue TF.

J Sex Med. 2007 Mar;4(2):341-6; discussion 346-7.

PMID:
17367429
8.

FK506 binding protein 12 is expressed in rat penile innervation and upregulated after cavernous nerve injury.

Sezen SF, Blackshaw S, Steiner JP, Burnett AL.

Int J Impot Res. 2002 Dec;14(6):506-12.

9.

The effect of FK1706 on erectile function following bilateral cavernous nerve crush injury in a rat model.

Hayashi N, Minor TX, Carrion R, Price R, Nunes L, Lue TF.

J Urol. 2006 Aug;176(2):824-9.

PMID:
16813955
10.

Functional sequelae of cavernous nerve injury in the rat: is there model dependency.

Mullerad M, Donohue JF, Li PS, Scardino PT, Mulhall JP.

J Sex Med. 2006 Jan;3(1):77-83.

PMID:
16409220
11.

FK506 and rapamycin neuroprotect erection and involve different immunophilins in a rat model of cavernous nerve injury.

Lagoda G, Sezen SF, Burnett AL.

J Sex Med. 2009 Jul;6(7):1914-23. doi: 10.1111/j.1743-6109.2009.01293.x. Epub 2009 Apr 24.

PMID:
19453873
12.

Erythropoietin promotes the recovery of erectile function following cavernous nerve injury.

Allaf ME, Hoke A, Burnett AL.

J Urol. 2005 Nov;174(5):2060-4.

PMID:
16217394
13.

The impact of shock wave therapy at varied energy and dose levels on functional and structural changes in erectile tissue.

Müller A, Akin-Olugbade Y, Deveci S, Donohue JF, Tal R, Kobylarz KA, Palese M, Mulhall JP.

Eur Urol. 2008 Mar;53(3):635-42. Epub 2007 Jun 27.

PMID:
17618733
14.

COX-2-10aa-PGIS gene therapy improves erectile function in rats after cavernous nerve injury.

Lin H, Yuan J, Ruan KH, Yang W, Zhang J, Dai Y, Wang R.

J Sex Med. 2013 Jun;10(6):1476-87. doi: 10.1111/jsm.12147. Epub 2013 Apr 3.

PMID:
23551902
15.

Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats.

Canguven O, Lagoda G, Sezen SF, Burnett AL.

J Urol. 2009 Jun;181(6):2816-22. doi: 10.1016/j.juro.2009.01.097. Epub 2009 Apr 17.

PMID:
19375729
16.

Both immediate and delayed intracavernous injection of autologous adipose-derived stromal vascular fraction enhances recovery of erectile function in a rat model of cavernous nerve injury.

Qiu X, Fandel TM, Ferretti L, Albersen M, Orabi H, Zhang H, Lin G, Lin CS, Schroeder T, Lue TF.

Eur Urol. 2012 Oct;62(4):720-7. doi: 10.1016/j.eururo.2012.02.003. Epub 2012 Feb 18. Erratum in: Eur Urol. 2012 Dec;62(6):e106. Orabi, Hazem [added].

17.

Poly(Adenosine diphosphate-ribose) polymerase inhibition preserves erectile function in rats after cavernous nerve injury.

Kendirci M, Zsengellér Z, Bivalacqua TJ, Gur S, Usta MF, Chen M, Szabó C, Hellstrom WJ.

J Urol. 2005 Nov;174(5):2054-9.

PMID:
16217393
18.

[Establishment of a rat model of erectile dysfunction after radical prostatectomy by crush injury or resection of the cavernous nerve].

Bian J, Dai YP, Sun XZ, Liu GH, Deng CH, Ye YL.

Nan Fang Yi Ke Da Xue Xue Bao. 2011 Feb;31(2):230-3. Chinese.

19.

The effect of vascular endothelial growth factor on a rat model of traumatic arteriogenic erectile dysfunction.

Lee MC, El-Sakka AI, Graziottin TM, Ho HC, Lin CS, Lue TF.

J Urol. 2002 Feb;167(2 Pt 1):761-7.

PMID:
11792968
20.

Neuroimmunophilin ligands protect cavernous nerves after crush injury in the rat: new experimental paradigms.

Valentine H, Chen Y, Guo H, McCormick J, Wu Y, Sezen SF, Hoke A, Burnett AL, Steiner JP.

Eur Urol. 2007 Jun;51(6):1724-31. Epub 2006 Nov 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk